2021 GLOBAL FINALIST
3billion
Digital Health Covid-19
By revolutionizing existing genetic testing procedures for rare diseases, 3billion is enabling more people to benefit from a faster, more accurate diagnosis at a lower cost. One test can analyze 20,000 genes to detect 7,000+ rare genetic diseases within just six weeks.
💸 Select investors: Magna Investment, AVentures Capital, Kakao Investment, Yuanta Investment, JW Asset, Korea Investment Securities, The Wells Investment
📌 HQ: Seoul, South Korea